These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Retinal pigment epithelium--the point about safety of antimalarial agents]. Vanheesbeke A Bull Soc Belge Ophtalmol; 2007; (304):47-58. PubMed ID: 17718227 [TBL] [Abstract][Full Text] [Related]
23. Long-term effectiveness of antimalarial drugs in rheumatic diseases. Aviña-Zubieta JA; Galindo-Rodriguez G; Newman S; Suarez-Almazor ME; Russell AS Ann Rheum Dis; 1998 Oct; 57(10):582-7. PubMed ID: 9893568 [TBL] [Abstract][Full Text] [Related]
24. High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists. Verburg RJ; Mahabali SD; Stiggelbout AM; Sont JK; van Laar JM J Rheumatol; 2002 Aug; 29(8):1653-8. PubMed ID: 12180724 [TBL] [Abstract][Full Text] [Related]
25. How Canadian and US rheumatologists treat moderate or aggressive rheumatoid arthritis: a survey. Maetzel A; Bombardier C; Strand V; Tugwell P; Wells G J Rheumatol; 1998 Dec; 25(12):2331-8. PubMed ID: 9858426 [TBL] [Abstract][Full Text] [Related]
27. [Evaluation of a practical use of synthetic antimalarials in the treatment of rheumatoid polyarthritis]. David-Chaussé J; David-Chaussé F; Picot C; Laporte G; Lagoarde J; Dehais J Rev Rhum Mal Osteoartic; 1971 Nov; 38(11):681-90. PubMed ID: 5151168 [No Abstract] [Full Text] [Related]
28. Antimalarials in rheumatology: efficacy and safety. Maksymowych W; Russell AS Semin Arthritis Rheum; 1987 Feb; 16(3):206-21. PubMed ID: 3547658 [No Abstract] [Full Text] [Related]
29. Patients opinion and adherence to antimalarials in lupus erythematosus and rheumatoid arthritis treatment. Cabral RTS; Klumb EM; Carneiro S J Dermatolog Treat; 2020 May; 31(3):264-269. PubMed ID: 30935255 [No Abstract] [Full Text] [Related]
30. Ophthalmologic considerations in using antimalarials in the United States. Rynes RI Lupus; 1996 Jun; 5 Suppl 1():S73-4. PubMed ID: 8803917 [TBL] [Abstract][Full Text] [Related]
32. Early detection of macular changes with multifocal ERG in patients on antimalarial drug therapy. Nebbioso M; Grenga R; Karavitis P J Ocul Pharmacol Ther; 2009 Jun; 25(3):249-58. PubMed ID: 19348599 [TBL] [Abstract][Full Text] [Related]
33. An ophthalmological view on the efficacy and safety of chloroquine versus hydroxychloroquine. Easterbrook M J Rheumatol; 1999 Sep; 26(9):1866-8. PubMed ID: 10493662 [No Abstract] [Full Text] [Related]
34. More thoughts about antimalarials: should one prescribe chloroquine? Esdaile JM J Rheumatol; 1999 Sep; 26(9):1868. PubMed ID: 10493663 [No Abstract] [Full Text] [Related]
35. The use of chloroquine and hydroxychloroquine for non-infectious conditions other than rheumatoid arthritis or lupus: a critical review. Wallace DJ Lupus; 1996 Jun; 5 Suppl 1():S59-64. PubMed ID: 8803913 [TBL] [Abstract][Full Text] [Related]
36. Antimalarial agents and lupus. Wallace DJ Rheum Dis Clin North Am; 1994 Feb; 20(1):243-63. PubMed ID: 8153401 [TBL] [Abstract][Full Text] [Related]
37. A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine. Chang WH; Katz BJ; Warner JE; Vitale AT; Creel D; Digre KB Retina; 2008; 28(10):1478-86. PubMed ID: 18997610 [TBL] [Abstract][Full Text] [Related]
38. Hydroxychloroquine in pregnant patients with systemic lupus erythematosus. Parke A; West B J Rheumatol; 1996 Oct; 23(10):1715-8. PubMed ID: 8895146 [TBL] [Abstract][Full Text] [Related]
39. (Hydroxy)-chloroquine retinal toxicity: two case reports and safety guidelines. Herman K; Leys A; Spileers W Bull Soc Belge Ophtalmol; 2002; (284):21-9. PubMed ID: 12161987 [TBL] [Abstract][Full Text] [Related]
40. Antimalarials in the treatment of rheumatoid arthritis. Zvaifler NJ Mod Treat; 1971 Nov; 8(4):769-77. PubMed ID: 4258497 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]